SNOA Sonoma Pharmaceuticals
Sonoma Pharmaceuticals earnings company data as of 7:49 PM ET 10/23
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 3 Nov | EPS | — | — | — |
| Rev | — | — | — |
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 1.01,3.03,5.03,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 10-Q | FORM 10-Q FOR JUN 2026 | Filing Doc | |
| DEF 14A | DEFINITIVE PROXY STATEMENT | Filing Doc | |
| DEFA14A | NOTICE OF ADJOURNMENT | Filing Doc | |
| DEFA14A | FORM DEFA14A | Filing Doc | |
| 424B5 | PROSPECTUS SUPPLEMENT | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 10-K | FORM 10-K FOR MAR 2026 | Filing Doc | |
| DEF 14A | DEFINITIVE PROXY STATEMENT | Filing Doc | |
| 8-K | 1.01,8.01,9.01 | Filing Doc | |
| 424B4 | PROSPECTUS | Filing Doc | |
| S-1/A | AMENDMENT NO. 1 TO FORM S-1 | Filing Doc | |
| S-1 | FORM S-1 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 10-Q | FORM 10-Q FOR DEC 2025 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| 10-Q | FORM 10-Q FOR SEP 2025 | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 424B5 | PROSPECTUS SUPPLEMENT | Filing Doc |
No filings match this filter.
Insider forms
Forms 3, 4 and 5 from EDGAR, 1 row shown
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.